Apoptosis Effects of L. Extract on Human MCF-7 Breast Cancer Cell Line:.

Amir Reza Gholipour, Leila Jafari, Mahsa Ramezanpour, Mehdi Evazalipour, Maral Chavoshi, Fatemeh Yousefbeyk, Saghi Jani Kargar Moghaddam, Mohammad Hossein Yekta Kooshali, Nahid Ramezanpour, Puyan Daei, Saeed Ghasemi, Masoud Hamidi
Author Information
  1. Amir Reza Gholipour: Medical Biotechnology Research Center, Guilan University of Medical Sciences, Rasht, Iran.
  2. Leila Jafari: Pediatric Cell and Gene Therapy Research Center, Gene, Cell and Tissue Research Institute, Tehran University of Medical Science Tehran, Iran.
  3. Mahsa Ramezanpour: Medical Biotechnology Research Center, Guilan University of Medical Sciences, Rasht, Iran.
  4. Mehdi Evazalipour: Department of Pharmaceutical Biotechnology, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.
  5. Maral Chavoshi: Department of Genetics and Developmental Biology, University of Vienna, Vienna, Austria.
  6. Fatemeh Yousefbeyk: Department of Pharmacognosy, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.
  7. Saghi Jani Kargar Moghaddam: Medical Biotechnology Research Center, Guilan University of Medical Sciences, Rasht, Iran.
  8. Mohammad Hossein Yekta Kooshali: Medical Biotechnology Research Center, Guilan University of Medical Sciences, Rasht, Iran.
  9. Nahid Ramezanpour: Medical Biotechnology Research Center, Guilan University of Medical Sciences, Rasht, Iran.
  10. Puyan Daei: Medical Biotechnology Research Center, Guilan University of Medical Sciences, Rasht, Iran.
  11. Saeed Ghasemi: Department of Medicinal Chemistry, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran.
  12. Masoud Hamidi: Medical Biotechnology Research Center, Guilan University of Medical Sciences, Rasht, Iran.

Abstract

Recently, the non-toxic properties of natural plant products have gained more focus as anticancer agents. Therefore, this study aimed to assess the apoptosis effects of the ethanolic extract of on the MCF-7 breast cancer cell line. In this experimental study, aerial parts of were collected in Lahijan city (Iran), and after confirmation, they were dried and extracted with ethanol for 24 h. Then, the total phenolic and flavonoid contents of the extract were measured. The 2,2-diphenyl-1-picrylhydrazyl radical scavenging assay was used to measure the antioxidant properties of the extract. Selected cell lines (MCF-7 and human dermal fibroblast) were cultured in 6-wells dishes (1×10 cells/well). After 72 h of treating the extract, cytotoxicity was assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. The expression of apoptotic genes (such as , , , and ) was studied by real-time polymerase chain reaction (PCR). The extract's total phenolic content was 31.30±02 μg of gallic acid equivalents/mg of dry extract, and the total flavonoid content was 49.61±04 μg of quercetin as equivalents/mg of extract. The antioxidant activity of was measured at the dose of 619.2 μg/μl, indicating that it decreases cancer cell viability and enhances apoptosis. Within the half maximal inhibitory concentrations, real-time PCR revealed substantial increases in (P<0.001), (P<0.05), and expression (P<0.05) in MCF-7 cells treated with . This study suggests that may cause apoptosis by oxidative stress in cancer cells.[GMJ.2022;11:e2484].

Keywords

References

  1. Chem Cent J. 2017 Jun 20;11(1):56 [PMID: 29086840]
  2. Cell Death Discov. 2022 Jun 9;8(1):282 [PMID: 35680784]
  3. 3 Biotech. 2013 Dec;3(6):439-459 [PMID: 28324424]
  4. BMC Complement Altern Med. 2012 Nov 16;12:221 [PMID: 23153304]
  5. J Biomed Sci. 2013 Mar 19;20:18 [PMID: 23506616]
  6. Biomed Res Int. 2014;2014:150845 [PMID: 25013758]
  7. Drug Metab Dispos. 2002 Feb;30(2):103-5 [PMID: 11792676]
  8. Bioorg Med Chem. 2020 Jan 15;28(2):115242 [PMID: 31866271]
  9. Molecules. 2010 Oct 21;15(10):7313-52 [PMID: 20966876]
  10. Int J Biochem Cell Biol. 2013 Dec;45(12):2821-31 [PMID: 24128857]
  11. Oxid Med Cell Longev. 2020 Oct 17;2020:5872645 [PMID: 33133347]
  12. Mol Cell Pharmacol. 2009;1(1):29-43 [PMID: 20333321]
  13. Eur J Cancer. 2011 Feb;47(3):339-46 [PMID: 20951575]
  14. Sci Rep. 2017 Jan 24;7:41191 [PMID: 28117408]
  15. World Neurosurg. 2017 Dec;108:94-100 [PMID: 28867321]
  16. Biochem Pharmacol. 2019 Apr;162:250-261 [PMID: 30668936]
  17. Evid Based Complement Alternat Med. 2018 Oct 03;2018:6274021 [PMID: 30402131]
  18. Trends Pharmacol Sci. 2005 Jun;26(6):318-26 [PMID: 15925707]
  19. Anticancer Drugs. 2011 Jul;22(6):481-7 [PMID: 21317766]
  20. Toxicol Pathol. 2007 Jun;35(4):495-516 [PMID: 17562483]
  21. J Food Sci Technol. 2018 Nov;55(11):4600-4607 [PMID: 30333656]
  22. Front Immunol. 2012 Jul 25;3:207 [PMID: 22848207]
  23. Daru. 2014 Jan 07;22(1):12 [PMID: 24397958]
  24. Phytomedicine. 2021 Jan;80:153402 [PMID: 33203590]
  25. Mol Biol Rep. 2022 Apr;49(4):2735-2743 [PMID: 35037194]
  26. 3 Biotech. 2019 Feb;9(2):58 [PMID: 30729082]
  27. Drug Resist Updat. 2004 Apr;7(2):97-110 [PMID: 15158766]
  28. Front Biosci. 2005 May 01;10:1881-96 [PMID: 15769673]
  29. Cell Death Differ. 2012 Jan;19(1):42-50 [PMID: 21959933]
  30. Eur J Med Chem. 2020 Sep 1;201:112446 [PMID: 32563811]
  31. Pharmacol Ther. 2022 Feb;230:107943 [PMID: 34182005]
  32. Apoptosis. 2021 Jun;26(5-6):235-247 [PMID: 33783663]
  33. Molecules. 2020 Jun 24;25(12): [PMID: 32599892]
  34. Cell Mol Biol (Noisy-le-grand). 2016 Apr 30;62(5):60-3 [PMID: 27188871]
  35. BMC Complement Altern Med. 2018 Aug 22;18(1):240 [PMID: 30134897]
  36. Med Hypotheses. 2000 Jul;55(1):29-35 [PMID: 11021322]
  37. Eur J Pharmacol. 2019 Nov 5;862:172655 [PMID: 31494078]
  38. Food Funct. 2021 Oct 4;12(19):9443-9455 [PMID: 34606555]
  39. Oncogene. 2017 Mar 23;36(12):1678-1686 [PMID: 27617579]
  40. Biomed Res Int. 2016;2016:5125836 [PMID: 27525270]
  41. J Med Chem. 2003 Dec 4;46(25):5395-401 [PMID: 14640548]
  42. J Natl Cancer Inst. 2017 Sep 1;109(9): [PMID: 28376154]
  43. Nutrients. 2016 Jul 28;8(8): [PMID: 27483305]
  44. Oncol Lett. 2019 Jan;17(1):603-615 [PMID: 30655807]
  45. Cell. 2004 Jan 23;116(2):205-19 [PMID: 14744432]
  46. FEBS Lett. 2006 Jan 23;580(2):533-8 [PMID: 16412432]
  47. J Cell Biochem. 2005 Aug 15;95(6):1120-34 [PMID: 15880691]
  48. Evid Based Complement Alternat Med. 2015;2015:534808 [PMID: 26457109]
  49. Mol Biol Rep. 2019 Oct;46(5):5131-5142 [PMID: 31317456]
  50. World J Gastroenterol. 2016 Apr 7;22(13):3564-72 [PMID: 27053848]
  51. Mini Rev Med Chem. 2011 Apr;11(4):298-344 [PMID: 21428901]
  52. J Ethnopharmacol. 2006 Apr 21;105(1-2):263-8 [PMID: 16361073]
  53. Evid Based Complement Alternat Med. 2016;2016:9612490 [PMID: 27999608]
  54. Cell Death Differ. 2018 Jan;25(1):37-45 [PMID: 29099482]
  55. Cell Death Dis. 2019 Feb 21;10(3):177 [PMID: 30792387]

Word Cloud

Created with Highcharts 10.0.0extractMCF-7studyapoptosiscancercelltotalP<0propertieshphenolicflavonoidmeasured2assayantioxidantexpressionreal-timePCRcontentμgequivalents/mg05cellsApoptosisBreastCancerRecentlynon-toxicnaturalplantproductsgainedfocusanticanceragentsThereforeaimedassesseffectsethanolicbreastlineexperimentalaerialpartscollectedLahijancityIranconfirmationdriedextractedethanol24contents2-diphenyl-1-picrylhydrazylradicalscavengingusedmeasureSelectedlineshumandermalfibroblastcultured6-wellsdishes1×10cells/well72treatingcytotoxicityassessedusing3-45-dimethylthiazol-2-yl-25-diphenyl-2H-tetrazoliumbromideMTTapoptoticgenesstudiedpolymerasechainreactionextract's3130±02gallicaciddry4961±04quercetinactivitydose619μg/μlindicatingdecreasesviabilityenhancesWithinhalfmaximalinhibitoryconcentrationsrevealedsubstantialincreases001treatedsuggestsmaycauseoxidativestress[GMJ202211:e2484]EffectsLExtractHumanCellLine:OxalisCorniculatebaxbcl-2p53

Similar Articles

Cited By